ICU MEDICAL INC (ICUI) Fundamental Analysis & Valuation

NASDAQ:ICUI • US44930G1076

Current stock price

125.85 USD
-2.93 (-2.28%)
At close:
125.85 USD
0 (0%)
After Hours:

This ICUI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. ICUI Profitability Analysis

1.1 Basic Checks

  • ICUI had positive earnings in the past year.
  • ICUI had a positive operating cash flow in the past year.
  • In multiple years ICUI reported negative net income over the last 5 years.
  • ICUI had a positive operating cash flow in 4 of the past 5 years.
ICUI Yearly Net Income VS EBIT VS OCF VS FCFICUI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

1.2 Ratios

  • ICUI has a Return On Assets of 0.02%. This is in the better half of the industry: ICUI outperforms 71.20% of its industry peers.
  • ICUI has a better Return On Equity (0.03%) than 71.74% of its industry peers.
  • ICUI's Return On Invested Capital of 2.43% is fine compared to the rest of the industry. ICUI outperforms 70.11% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ICUI is significantly below the industry average of 9.18%.
  • The last Return On Invested Capital (2.43%) for ICUI is above the 3 year average (1.99%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.02%
ROE 0.03%
ROIC 2.43%
ROA(3y)-1.15%
ROA(5y)0.08%
ROE(3y)-2.45%
ROE(5y)-0.91%
ROIC(3y)1.99%
ROIC(5y)2.63%
ICUI Yearly ROA, ROE, ROICICUI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10

1.3 Margins

  • ICUI's Profit Margin of 0.03% is fine compared to the rest of the industry. ICUI outperforms 71.74% of its industry peers.
  • ICUI's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 4.90%, ICUI is in the better half of the industry, outperforming 69.57% of the companies in the same industry.
  • ICUI's Operating Margin has declined in the last couple of years.
  • ICUI has a Gross Margin of 36.84%. This is in the lower half of the industry: ICUI underperforms 71.74% of its industry peers.
  • In the last couple of years the Gross Margin of ICUI has remained more or less at the same level.
Industry RankSector Rank
OM 4.9%
PM (TTM) 0.03%
GM 36.84%
OM growth 3Y57.68%
OM growth 5Y-13.09%
PM growth 3YN/A
PM growth 5Y-65.63%
GM growth 3Y6.38%
GM growth 5Y0.29%
ICUI Yearly Profit, Operating, Gross MarginsICUI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ICUI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICUI is destroying value.
  • Compared to 1 year ago, ICUI has more shares outstanding
  • The number of shares outstanding for ICUI has been increased compared to 5 years ago.
  • Compared to 1 year ago, ICUI has an improved debt to assets ratio.
ICUI Yearly Shares OutstandingICUI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
ICUI Yearly Total Debt VS Total AssetsICUI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • ICUI has an Altman-Z score of 2.05. This is not the best score and indicates that ICUI is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ICUI's Altman-Z score of 2.05 is fine compared to the rest of the industry. ICUI outperforms 61.41% of its industry peers.
  • The Debt to FCF ratio of ICUI is 15.58, which is on the high side as it means it would take ICUI, 15.58 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of ICUI (15.58) is better than 71.20% of its industry peers.
  • A Debt/Equity ratio of 0.60 indicates that ICUI is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.60, ICUI is not doing good in the industry: 61.96% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 15.58
Altman-Z 2.05
ROIC/WACC0.25
WACC9.77%
ICUI Yearly LT Debt VS Equity VS FCFICUI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • ICUI has a Current Ratio of 2.39. This indicates that ICUI is financially healthy and has no problem in meeting its short term obligations.
  • ICUI has a Current ratio (2.39) which is in line with its industry peers.
  • A Quick Ratio of 1.15 indicates that ICUI should not have too much problems paying its short term obligations.
  • The Quick ratio of ICUI (1.15) is worse than 72.28% of its industry peers.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.15
ICUI Yearly Current Assets VS Current LiabilitesICUI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ICUI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 24.76% over the past year.
  • The Earnings Per Share has been growing slightly by 1.71% on average over the past years.
  • Looking at the last year, ICUI shows a decrease in Revenue. The Revenue has decreased by -6.33% in the last year.
  • ICUI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.91% yearly.
EPS 1Y (TTM)24.76%
EPS 3Y5.87%
EPS 5Y1.71%
EPS Q2Q%-9.48%
Revenue 1Y (TTM)-6.33%
Revenue growth 3Y-0.72%
Revenue growth 5Y11.91%
Sales Q2Q%-13.78%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.23% on average over the next years. This is quite good.
  • ICUI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.49% yearly.
EPS Next Y6.62%
EPS Next 2Y9.98%
EPS Next 3Y9.85%
EPS Next 5Y9.23%
Revenue Next Year-1.33%
Revenue Next 2Y1.52%
Revenue Next 3Y3.23%
Revenue Next 5Y4.49%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICUI Yearly Revenue VS EstimatesICUI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
ICUI Yearly EPS VS EstimatesICUI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. ICUI Valuation Analysis

4.1 Price/Earnings Ratio

  • ICUI is valuated correctly with a Price/Earnings ratio of 16.22.
  • Based on the Price/Earnings ratio, ICUI is valued cheaper than 83.70% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of ICUI to the average of the S&P500 Index (25.71), we can say ICUI is valued slightly cheaper.
  • Based on the Price/Forward Earnings ratio of 15.21, the valuation of ICUI can be described as correct.
  • ICUI's Price/Forward Earnings ratio is rather cheap when compared to the industry. ICUI is cheaper than 84.78% of the companies in the same industry.
  • ICUI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.83.
Industry RankSector Rank
PE 16.22
Fwd PE 15.21
ICUI Price Earnings VS Forward Price EarningsICUI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ICUI indicates a rather cheap valuation: ICUI is cheaper than 82.61% of the companies listed in the same industry.
  • ICUI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ICUI is cheaper than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 37.51
EV/EBITDA 13.19
ICUI Per share dataICUI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ICUI does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.45
PEG (5Y)9.5
EPS Next 2Y9.98%
EPS Next 3Y9.85%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ICUI Dividend Analysis

5.1 Amount

  • No dividends for ICUI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ICUI Fundamentals: All Metrics, Ratios and Statistics

ICU MEDICAL INC

NASDAQ:ICUI (3/13/2026, 8:00:02 PM)

After market: 125.85 0 (0%)

125.85

-2.93 (-2.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-19
Earnings (Next)05-06
Inst Owners116.08%
Inst Owner Change-1.88%
Ins Owners0.96%
Ins Owner Change5.9%
Market Cap3.11B
Revenue(TTM)2.23B
Net Income(TTM)732.00K
Analysts83.33
Price Target187.27 (48.8%)
Short Float %4.25%
Short Ratio3.91
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.77%
Min EPS beat(2)10.68%
Max EPS beat(2)38.85%
EPS beat(4)4
Avg EPS beat(4)29.63%
Min EPS beat(4)10.68%
Max EPS beat(4)38.85%
EPS beat(8)8
Avg EPS beat(8)31.35%
EPS beat(12)12
Avg EPS beat(12)27.15%
EPS beat(16)15
Avg EPS beat(16)20.28%
Revenue beat(2)1
Avg Revenue beat(2)0.72%
Min Revenue beat(2)-0.98%
Max Revenue beat(2)2.43%
Revenue beat(4)2
Avg Revenue beat(4)0.69%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)3.09%
Revenue beat(8)5
Avg Revenue beat(8)0.8%
Revenue beat(12)6
Avg Revenue beat(12)-0.83%
Revenue beat(16)7
Avg Revenue beat(16)-0.86%
PT rev (1m)1.21%
PT rev (3m)1.21%
EPS NQ rev (1m)-1.51%
EPS NQ rev (3m)-1.51%
EPS NY rev (1m)0.87%
EPS NY rev (3m)0.87%
Revenue NQ rev (1m)-0.21%
Revenue NQ rev (3m)-0.21%
Revenue NY rev (1m)1%
Revenue NY rev (3m)-0.13%
Valuation
Industry RankSector Rank
PE 16.22
Fwd PE 15.21
P/S 1.39
P/FCF 37.51
P/OCF 17.28
P/B 1.46
P/tB N/A
EV/EBITDA 13.19
EPS(TTM)7.76
EY6.17%
EPS(NY)8.27
Fwd EY6.57%
FCF(TTM)3.35
FCFY2.67%
OCF(TTM)7.28
OCFY5.79%
SpS90.37
BVpS86.02
TBVpS-0.38
PEG (NY)2.45
PEG (5Y)9.5
Graham Number122.55
Profitability
Industry RankSector Rank
ROA 0.02%
ROE 0.03%
ROCE 3.08%
ROIC 2.43%
ROICexc 2.66%
ROICexgc 7.78%
OM 4.9%
PM (TTM) 0.03%
GM 36.84%
FCFM 3.71%
ROA(3y)-1.15%
ROA(5y)0.08%
ROE(3y)-2.45%
ROE(5y)-0.91%
ROIC(3y)1.99%
ROIC(5y)2.63%
ROICexc(3y)2.16%
ROICexc(5y)3.42%
ROICexgc(3y)6.21%
ROICexgc(5y)6.59%
ROCE(3y)2.51%
ROCE(5y)3.33%
ROICexgc growth 3Y68.14%
ROICexgc growth 5Y-6.18%
ROICexc growth 3Y65.14%
ROICexc growth 5Y-20.85%
OM growth 3Y57.68%
OM growth 5Y-13.09%
PM growth 3YN/A
PM growth 5Y-65.63%
GM growth 3Y6.38%
GM growth 5Y0.29%
F-Score6
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 15.58
Debt/EBITDA 4.09
Cap/Depr 48.33%
Cap/Sales 4.35%
Interest Coverage 1.31
Cash Conversion 58%
Profit Quality 11315.8%
Current Ratio 2.39
Quick Ratio 1.15
Altman-Z 2.05
F-Score6
WACC9.77%
ROIC/WACC0.25
Cap/Depr(3y)43.46%
Cap/Depr(5y)52.62%
Cap/Sales(3y)4.09%
Cap/Sales(5y)4.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.76%
EPS 3Y5.87%
EPS 5Y1.71%
EPS Q2Q%-9.48%
EPS Next Y6.62%
EPS Next 2Y9.98%
EPS Next 3Y9.85%
EPS Next 5Y9.23%
Revenue 1Y (TTM)-6.33%
Revenue growth 3Y-0.72%
Revenue growth 5Y11.91%
Sales Q2Q%-13.78%
Revenue Next Year-1.33%
Revenue Next 2Y1.52%
Revenue Next 3Y3.23%
Revenue Next 5Y4.49%
EBIT growth 1Y6.35%
EBIT growth 3Y56.54%
EBIT growth 5Y-2.74%
EBIT Next Year28.75%
EBIT Next 3Y15.51%
EBIT Next 5Y12.24%
FCF growth 1Y-27.23%
FCF growth 3YN/A
FCF growth 5Y-7.51%
OCF growth 1Y-11.85%
OCF growth 3YN/A
OCF growth 5Y-4.19%

ICU MEDICAL INC / ICUI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ICU MEDICAL INC (ICUI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ICUI.


Can you provide the valuation status for ICU MEDICAL INC?

ChartMill assigns a valuation rating of 5 / 10 to ICU MEDICAL INC (ICUI). This can be considered as Fairly Valued.


What is the profitability of ICUI stock?

ICU MEDICAL INC (ICUI) has a profitability rating of 5 / 10.


Can you provide the financial health for ICUI stock?

The financial health rating of ICU MEDICAL INC (ICUI) is 4 / 10.


What is the expected EPS growth for ICU MEDICAL INC (ICUI) stock?

The Earnings per Share (EPS) of ICU MEDICAL INC (ICUI) is expected to grow by 6.62% in the next year.